SSR-411298

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameSSR-411298
Drug Alias NameSAR-411298SSR-411298
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnandamide amidohydrolase inhibitors
TargetsAnandamide amidohydrolase
Therapy Area/IndicationsDepressive Disorder, MajorCancer PainPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkraineSlovakia +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, MajorCancer PainPain

Other Information

ATC CodeN/A
Related LinksN/A